http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016540765-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-69 |
| filingDate | 2014-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2016540765-A |
| titleOfInvention | Method for producing reverse transcriptase inhibitor |
| abstract | The present invention relates to 3- (substituted phenoxy) -1-[(5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl) methyl])-pyridine-2 ( The present invention relates to a novel synthesis method of 1H) -one derivatives. The compounds synthesized by the methods of the present invention are HIV reverse transcriptase inhibitors useful for the inhibition of reverse transcriptase and HIV replication and the treatment of human immunodeficiency virus infection in humans. [Selection] Figure 1 |
| priorityDate | 2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 226.